{
    "code": 0,
    "data": [
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "To Review Consider And Approve The Standalone Unaudited Financial Results For The Quarter And Half Year Ended On 30Th September 2025 Along With Limited Review Report.",
            "news_body": "To review consider and approve the Standalone Unaudited  Financial Results for the quarter and half year ended on 30th September 2025 along with Limited Review Report",
            "news_id": "3ade2adc-b49e-4e93-97f8-27c3126c7f9f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8064f5b-d82a-4a8b-802b-f158d5cf19f4.pdf",
            "news_date": "2025-11-13 19:15:18",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended 30Th June 2025",
            "news_body": "Un-Audited Financial Results for the quarter ended 30th June 2025",
            "news_id": "decbc563-5d51-4411-aac1-5d65e13bd4dd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fddc35e9-0f9d-4501-a764-1ab2c5aff860.pdf",
            "news_date": "2025-08-12 19:33:28",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Financial Result For The Financial Year Ended 31.03.2025",
            "news_body": "Audited Financial Result for the Financial Year ended 31.03.2025",
            "news_id": "f7b8f8ee-0cb1-4820-bc16-87652bc4174a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d1cddcdc-687e-4188-a72a-e3c7f83feaa3.pdf",
            "news_date": "2025-05-30 18:36:25",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un Audited Financial Result For Quarted Dec 2024",
            "news_body": "Unaudited financial result for quarter ended Dec 2024",
            "news_id": "43620431-4701-493b-96a5-5349667c33df",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ee82a8f8-fe8d-40f0-bc7d-12a02d04e8d2.pdf",
            "news_date": "2025-02-11 17:30:05",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "OUTCOME OF BOARD MEETING HELD ON 14TH NOVEMBER, 2024 ALONGWITH FINANCIAL RESULTS FOR QUARTER AND HALF YEAR ENDED 30 SEPTEMBER 2024",
            "news_body": "OUTCOME OF BOARD MEETING ALONGWITH FINANCIAL RESULTS",
            "news_id": "5ef4f552-92ce-4760-996c-e11fb87bf60e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b9c05a38-c767-42c8-a981-e638558f7204.pdf",
            "news_date": "2024-11-14 19:17:28",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results Of The Company For The Quarter Ended On 30Th June, 2024 Along With Limited Review Report Thereon",
            "news_body": "Un-audited financial results for the quarter ended 30th June 2024",
            "news_id": "32030940-96ae-451f-a74c-6eb224b8f5d9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1583fef3-4b9d-4be0-9d3f-d3a3064125d5.pdf",
            "news_date": "2024-08-13 18:33:41",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Results For Quarter And Year Ended 31.03.2024",
            "news_body": "Audited Results for Quarter and Year Ended 31.03.2024.",
            "news_id": "b1c5c1c6-440a-4504-92db-4ca0c2274a41",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7656dcca-23d1-4fbf-a17c-b14ad6105854.pdf",
            "news_date": "2024-05-30 18:48:18",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Un-Audited Financial Results Of The Company For The Quarter As Well As Nine Months Ended On 31St December, 2023 Along With Segment Results And Limited Review Report In Terms Of Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Pursuant to regulation 33 of SEBI (LODR), Regulations, 2015, we are hereby enclosing un-audited financial results for the quarter as well as nine months ended 31st December, 2023 duly approved by the board of directors at its meeting held today i.e. 06th February, 2024 together with segment results and limited review report thereon. (Copy of Unaudited financial results along with limited review report is enclosed with this letter in searchable mode.)",
            "news_id": "4cc6f80e-05d0-4d38-8c68-8452dae48781",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c72fcbca-eb71-48a8-9399-2db1533f5419.pdf",
            "news_date": "2024-02-06 20:47:09",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Un-Audited Financial Results Of The Company For The Quarter As Well As Half Year Ended On 30Th September, 2023 Along With Segment Results, Statement Of Assets And Liabilities And Cash Flow Statement With Limited Review Report In Terms Of Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Submission of Un-audited Financial Results and limited review report as per regulation 33 of SEBI (LODR) Regulations, 2015 for the Quarter and half year ended 30th September, 2023.",
            "news_id": "84fa294d-af5e-4c55-a0fd-e2272c5f99d8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d4405c9a-6f77-45f2-9240-f3cb14b346da.pdf",
            "news_date": "2023-11-09 19:33:49",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Un-Audited Financial Results Of The Company For The Quarter Ended 30Th June, 2023 And Limited Review Report As Per Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Submission of Un-Audited Financial Results of the Company for the Quarter ended 30th June, 2023 and Limited Review Report as per Regulation 33 of SEBI  (LODR) Regulations, 2015",
            "news_id": "d57f195b-7f67-4bb7-8e92-47a6a79a8757",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbb4ecac-cd52-4333-94fd-4f05ea6e9e5c.pdf",
            "news_date": "2023-08-14 18:12:36",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Audited Financial Results For The Quarter As Well As Year Ended 31St March, 2023 In Terms Of Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are here enclosing the Audited Financial Results for the quarter as well as year ended 31st March, 2023 duly approved by the Board of Directors at its meeting held today i.e. Tuesday, 30th May, 2023 together with Audit Report thereon, Statement of assets and liabilities, Cash Flow Statement & declaration by the Managing Director of Company pursuant to second proviso of Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
            "news_id": "33e05b92-6a97-467f-9d83-5aaa2119e723",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9b236e5b-4b5c-4c3d-86ab-410a106b6d74.pdf",
            "news_date": "2023-05-30 18:54:44",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Unaudited Financial Results For Quarter & Nine Months Ended 31 Dec 2022.",
            "news_body": "In compliance with Regulation 33 of SEBI (LODR) Regulations, 2015, the Company hereby submits Standalone Un-audited Financial Results for the Quarter as well as Nine Months ended December 31, 2022 duly approved by the Board of Directors of the Company at its meeting held on Tuesday, 14th February, 2023 together with Limited Review Reports thereon.<BR>",
            "news_id": "67565077-715c-41a1-8a89-4f4b1af29b4e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ebfd4328-d2f8-4317-91f7-86d267f2c048.pdf",
            "news_date": "2023-02-14 17:23:04",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure Of Related Party Transactions For The Half Year Ended On 30Th September , 2022",
            "news_body": "Pursuant to Regulation 23(9) SEBI (Listing Obligations and Disclosure Requirements)Regulations,2015, please find enclosed herewith the Disclosure of Related party Transactions of the Company for the half year ended 30th September , 2022",
            "news_id": "11f9f403-4504-4fa4-9b57-81b6747707ba",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ea436d8a-e62e-42bb-9f04-7abc101861c8.pdf",
            "news_date": "2022-11-28 18:35:26",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results For The Period Ended On 30Th September 2022",
            "news_body": "<BR> With reference to the above captioned subject, we would like to inform that Board of Directors of the Company in their meeting (Serial Number 03/2022-23) held on today, approved of the Un-audited Financial Results of the Company for the Quarter and Half year ended on 30th September, 2022 with Segment results, Statement of Assets and Liabilities, Cash Flow Statement and Limited Review Report thereon<BR>",
            "news_id": "157024e9-758e-425e-ad5b-ff127c3f2ecd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cdf15774-853d-42e7-8c36-15e4e5195b99.pdf",
            "news_date": "2022-11-14 19:48:01",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Un-Audited Financial Result And Limited Review Report Thereon For The Quarter Ended On 30Th June, 2022.   <BR> <BR>",
            "news_body": "This is in continuation of our letter dated 2nd August, 2022 regarding information of Board Meeting for consideration and approval of un-audited Financial Results for the quarter ended on 30th June, 2022.<BR> <BR> Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are pleased to submit the Un-audited Financial Results together with Limited Review Report thereon for the quarter ended 30th June 2022 duly approved by the Board of Directors of the Company at its meeting held today i.e. on Tuesday, 9th August, 2022 at the Registered office of the Company. Copy of Unaudited Financial Results along with Limited Review Report is enclosed with this letter (searchable PDF mode).<BR> <BR> Further, copy of Un-Audited Financial Statements shall also be submitted in XBRL mode within 24 hours from the conclusion of Board Meeting.  <BR> <BR> <BR> <BR>",
            "news_id": "98dde565-9a65-4372-9e0d-5b6f513c9820",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0e68a78d-44bd-4e93-a61e-d2c9fe02efc3.pdf",
            "news_date": "2022-08-09 17:57:36",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure  Of Related Party Transactions  For The Half Year Ended Oon 31St March , 2022",
            "news_body": "Pursuant to Regulation 23(9) SEBI(Listing Obligations and Disclosure Requirements) Regulations,2015, please find enclosed herewith the Disclosure  of Related party Transactions of the Company  for the half year ended 31st March , 2022You are requested to please take on record the above said document for your reference and further needful.",
            "news_id": "6acb7781-aafe-426d-af14-29c352e1ceef",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43dd4d76-0409-489a-9ab5-646040b7565e.pdf",
            "news_date": "2022-06-10 17:47:17",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure  Of Related Party Transactions  For The Half Year Ended Oon 31St March , 2022",
            "news_body": "Pursuant to Regulation 23(9) SEBI(Listing Obligations and Disclosure Requirements) Regulations,2015, please find enclosed herewith the Disclosure  of Related party Transactions of the Company  for the half year ended 31st March , 2022You are requested to please take on record the above said document for your reference and further needful.",
            "news_id": "216f7d12-fa14-4368-af3c-d5815df81982",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83f3fcb1-c73f-44a7-adfa-a47f5a1a1b34.pdf",
            "news_date": "2022-06-10 17:46:14",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure  Of Related Party Transactions  For The Half Year Ended On 31St March , 2022",
            "news_body": "Pursuant to Regulation 23(9) SEBI(Listing Obligations and Disclosure Requirements) Regulations,2015, please find enclosed herewith the Disclosure  of Related party Transactions of the Company  for the half year ended 31st March , 2022You are requested to please take on record the above said document for your reference and further needful.",
            "news_id": "a8d08042-5b97-42d3-a9b3-b7da83d6fc88",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a58893f9-9a2e-4283-b1b9-434480177ff0.pdf",
            "news_date": "2022-06-10 17:36:25",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Audited Financial Results For The Quarter As Well As Year Ended 31St March, 2022 In Terms Of Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are here enclosing the Audited Financial Results for the quarter as well as year ended 31st March, 2022 duly approved by the Board of Directors at its meeting held today i.e. Monday, 30th May, 2022 together with Audit Report thereon, Statement of assets and liabilities, Cash Flow Statement & declaration by the Managing Director of Company pursuant to second proviso of Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 .<BR> <BR> Further above said results shall also be submitted in XBRL mode within 24 hours from the conclusion of Board Meeting. <BR> <BR> The results shall also be uploaded on the Company''s website i.e. www.biofilgroup.net and on the website of the Stock Exchanges i.e., at www.bseindia.com & www.nseindia.com and extracts of the aforesaid results shall also be published in Hindi (Vernacular) and widely circulated English Newspaper<BR>",
            "news_id": "72bc93f9-762a-444c-9310-c45791970470",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f6872a47-e567-43b3-805e-da9ca06fbe78.pdf",
            "news_date": "2022-05-30 20:21:39",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Un-Audited Financial Result For The Quarter And Nine Months Ended On 31St December, 2021 Together With Limited Review Report Thereon.",
            "news_body": "Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are hereby enclosing Un-Audited Financial Results together with Limited Review Report thereon for the quarter and nine months ended on 31st December, 2021 duly approved by the Board of Directors of the Company at its meeting held today i.e. Monday, 14th February, 2022. Copy of Unaudited Financial Results is enclosed with this letter.Further, copy of Un-Audited Financial Statements shall also be submitted in XBRL mode within 24 hours from the conclusion of Board Meeting.",
            "news_id": "3bc06dc0-2fc5-4918-862e-b56d03860c8b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58c726d4-b3e0-4825-96ec-ce8b655c18d2.pdf",
            "news_date": "2022-02-14 17:40:02",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Resubmission Of Cash Flow Statement For The Half Year Ended 30Th September, 2021 In Terms Of Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Pursuant to Regulation 33(3)(d) of SEBI(LODR) Regulations, 2015, the Un-audited Financial Statements of the Company for the Quarter and Half Year ended on 30th September, 2021 along with the Statement of Assets and Liabilities, Cash Flow Statement, Segment Reporting and Limited Review Report in the PDF Format as well as in XBRL has been submitted in the prescribed time.  <BR> <BR> Further, we would like to inform that due to typographically error of wrong entry of profit before tax and failing to enter amount of Adjustments for provisions, current in the Cash Flow Statement, PDF file was wrongly uploaded on stock exchange, however please note that there was no change in Un-audited financial results, Statement of assets & Liabilities and Segment Reporting, therefore we hereby submitting Revised Cash Flow Statement only for half year ended 30th September, 2021 after correction for your reference and records.  <BR> <BR>",
            "news_id": "ce76a6a4-ec74-4d16-bdca-645d86dd4cc5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb61d808-abe8-474c-886d-94051ff84d9c.pdf",
            "news_date": "2021-11-13 18:09:48",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Un-Audited Financial Result For The Quarter And Half Year Ended On 30Th September, 2021 In Terms Of Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are hereby enclosing Un-Audited Financial Results together with Limited Review Report thereon for the quarter and half year ended on 30th September, 2021 duly approved by the Board of Directors of the Company at its meeting held today i.e. on Friday, 12th November, 2021. <BR> <BR> Pursuant to the provisions of Regulation 33 (f) & (g) of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we have also enclosed Statement of Assets and Liabilities and Cash Flow Statement for the half year ended on 30th September 2021.<BR> <BR> Further, above Un-Audited Financial Statements shall also be submitted in XBRL mode within 24 hours from the conclusion of Board Meeting.<BR> <BR> <BR>",
            "news_id": "389a9463-b634-49dc-863f-8e5eb51ec3bf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27f8cd95-f658-4e63-a7a9-cc1915e36253.pdf",
            "news_date": "2021-11-12 16:36:10",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, 12Th November, 2021 Pursuant To Regulation30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "With reference to the above captioned subject, we would like to inform that Board of Directors of the Company in their meeting held on today, i.e Friday 12th day of November 2021, has inter alia, approved the Un-audited Financial Results of the Company for the Quarter and Half year ended on 30th September, 2021 along with Segment Report, Statement of Assets and Liabilities, Cash Flow Statement and Limited Review Report thereon along with other routine businesses. Copy of results being submitted separately.<BR> <BR> The Meeting of Board of Directors commenced at 3.00 p.m. and concluded at 4.30 p.m.<BR> <BR> This is for your information and record <BR> <BR>",
            "news_id": "dde2a6ee-b578-46cf-b637-12b2d4b5abe8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a80cf618-df90-4fee-a5b6-8cbff4518ead.pdf",
            "news_date": "2021-11-12 16:32:46",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Un-Audited Financial Result Of The Company For The Quarter Ended On 30Th June, 2021 And Limited Review Report As Per Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Pursuant to the provisions of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, we are hereby enclosing Un-Audited Financial Results together with Limited Review Report thereon for the quarter 30th June 2021 duly approved by the Board of Directors of the Company at its meeting held today i.e. on Friday, 13th August 2021 at the Registered office of the Company. Copy of Unaudited Financial Results along with Limited Review Report is enclosed with this letter (searchable PDF mode).<BR> <BR> Further, copy of Un-Audited Financial Statements shall also be submitted in XBRL mode within 24 hours from the conclusion of Board Meeting<BR>",
            "news_id": "6b889eb6-ca72-44c6-86cb-dcd6186a8593",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=83775cb4-99c0-426c-9079-04a03d802f13.pdf",
            "news_date": "2021-08-13 18:02:04",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday, 13Th August 2021 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "With reference to the above-mentioned subject and as per Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board of the Directors of the Company in their meeting (No. 03/2021-22) held on today i.e. Friday 13th day of August 2021, following matters have been inter alia transacted along with other routine businesses:-",
            "news_id": "e4d6d91f-9660-4de5-ad61-781608f0a113",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=62a91ced-cc07-4d49-8480-cafb2d51c2d6.pdf",
            "news_date": "2021-08-13 17:59:56",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure  Of Related Party Transactions  For The Half Year Ended 31St March , 2021",
            "news_body": "Pursuant to Regulation 23(9) SEBI(Listing Obligations and Disclosure Requirements) Regulations,2015, please find enclosed herewith the Disclosure  of Related party Transactions of the Company  for the half year ended 31st March , 2021",
            "news_id": "4bab225c-4113-4091-aae2-cc36fc1f1b59",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7039d0a4-b8ff-49aa-a185-d41f422830fc.pdf",
            "news_date": "2021-07-24 13:59:29",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Disclosure  Of Related Party Transactions  For The Half Year Ended 31St March , 2021",
            "news_body": "Pursuant to Regulation 23(9) SEBI(Listing Obligations and Disclosure Requirements) Regulations,2015, please find enclosed herewith the Disclosure  of Related party Transactions of the Company  for the half year ended 31st March , 2021",
            "news_id": "a04561c6-76f2-45ee-a14f-80dd88e2edfc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3c73527-d5bb-4dbd-933f-8e7637395a5d.pdf",
            "news_date": "2021-07-24 13:38:01",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Audited Financial Results For The Quarter As Well As Year Ended 31St March, 2021 In Terms Of Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to submit the Audited Financial Results for the quarter as well as year ended 31st March,2021 duly approved by the Board at its meeting held today Wednesday, 30th June, 2021 along with Audit Report thereon, Statement of assets and liabilities, Cash Flow Statement, Segment Reporting & declaration by the Managing Director of Company pursuant to second proviso of Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 .",
            "news_id": "9322aac9-135f-4275-9100-7f06f81963ea",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9efa156-7e70-4827-88da-8612b8485dd9.pdf",
            "news_date": "2021-06-30 17:24:19",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Submission Of Audited Financial Results For The Quarter As Well As Year Ended 31St March, 2021 In Terms Of Regulation 33 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "In compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to submit the Audited Financial Results for the quarter as well as year ended 31st March,2021 duly approved by the Board at its meeting held today Wednesday, 30th June, 2021 along with Audit Report thereon, Statement of assets and liabilities, Cash Flow Statement, Segment Reporting & declaration by the Managing Director of Company pursuant to second proviso of Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 .",
            "news_id": "5e4eebb3-9716-455d-86ef-6fa36150fe29",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed005c72-0fd1-4d73-b35d-d401274afc03.pdf",
            "news_date": "2021-06-30 17:23:38",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "BIOFILCHEM",
            "disp": "Biofil Chemicals",
            "bse_code": 524396,
            "isin": "INE829A01014",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held On Wednesday 30Th June 2021 Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.",
            "news_body": "Dear Sir/Madam,<BR> <BR> With reference to the above captioned subject, we would like to inform you that Board of Directors of the Company in their meeting (Serial No. 02/2021-22) held on today i.e., Wednesday, 30th day of June, 2021, has approved following matters along with other routine businesses <BR> 1. Approval of Audited Financial Results of the Company for the quarter as well as year ended 31st March, 2021 along with Audit Report thereon, Statement of assets and liabilities, Cash Flow Statement, Segment Reporting & declaration by the Managing Director of Company pursuant to second proviso of Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.<BR> 2. Appointment of Shri Satish Beohar  (DIN: 09220291) as an Additional Director as well as Independent Director of the Company for a term of five years from 30th June, 2021 to 29th June, 2026 subject to approval by the members at ensuing Annual General Meeting.<BR> <BR> <BR>",
            "news_id": "03a99846-0314-44b7-b857-e6548ceb4039",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f541fae0-8872-426f-9b11-cd706e574e83.pdf",
            "news_date": "2021-06-30 17:21:14",
            "seo": "biofil-chem-pharma-ltd",
            "ltp": 37.86,
            "ch": 0.490000000000002,
            "pch": 1.3112122023013166,
            "inst": "EQUITY",
            "ts": 0.01,
            "ls": 1,
            "mtp": 1,
            "sid": 4136,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}